Retraction
Inter- and intraobserver agreement of the quantitative assessment of [ 99m Tc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer
Paper Information
Record ID:
33127
Journal:
Publication Date:
December 01, 2020
Retraction Date:
October 12, 2021
(4.1 years years ago)
Subjects:
Institutions:
- Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King’s College London, 4th Floor, Lambeth Wing, St Thomas’ Hospital, Westminster Bridge Road, London, SE1 7EH, UK
- King’s College London & Guy’s and St. Thomas’ PET Centre, London, UK
- Department of Research and Development, NanoMab Technology Limited, Shanghai, People’s Republic of China
- Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China
- Department of Radiology, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
Countries:
Article Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (7)
7
Total Citations4
Post-Retraction(57.1%)
1
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
1
After 2+ years
772
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe
Guillermina Ferro‐Flores, Blanca Ocampo‐García, Pedro Cruz-Nova et al. (11 authors)
Pharmaceutics
Open Access
Published: Nov 2023
7 citations
7 citations
772 days after retraction
Novel Dual-Mode NIR-II/MRI Nanoprobe Targeting PD-L1 Accurately Evaluates the Efficacy of Immunotherapy for Triple-Negative Breast Cancer
Wan-Ling Liu, Yong‐Qu Zhang, Xiangjie Luo et al. (11 authors)
International Journal of Nanomedicine
Open Access
Published: Sep 2023
8 citations
8 citations
689 days after retraction
Molecular imaging of immune checkpoints in oncology: Current and future applications
Shushan Ge, Tongtong Jia, Jihui Li et al. (6 authors)
Cancer Letters
Published: Aug 2022
9 citations
9 citations
319 days after retraction
Application of molecular imaging in immune checkpoints therapy: From response assessment to prognosis prediction
Wan‐Ling Liu, Yong‐Qu Zhang, Liangtao Li et al. (10 authors)
Critical Reviews in Oncology/Hematology
Published: Jun 2022
5 citations
5 citations
253 days after retraction
Retraction Note to: Inter- and intraobserver agreement of the quantitative assessment of [99mTc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer
D.J. Hughes, Gitasha Chand, Vicky Goh et al. (4 authors)
EJNMMI Research
Open Access
Published: Oct 2021
Same day as retraction
Molecular Imaging and the PD-L1 Pathway: From Bench to Clinic
David Leung, Samuel J. Bonacorsi, R. Adam Smith et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Aug 2021
18 citations
18 citations
50 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
4.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025